{"id":"W2888908066","doi":"10.1007/s12325-018-0772-3","title":"Burden of Infections Among Chronic Myeloid Leukemia Patients Receiving Dasatinib or Nilotinib: A Real-World Retrospective Healthcare Claims Study in the United States","year":2018,"lang":"en","type":"article","venue":"Advances in Therapy","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"Novartis Pharmaceuticals Corporation","keywords":"Nilotinib; Dasatinib; Medicine; Myeloid leukemia; Internal medicine; Cohort; Retrospective cohort study; Oncology; Imatinib","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006933592,0.0003056967,0.0005061479,0.001157036,0.0004013942,0.001118324,0.0005277668,0.0007072109,0.001150461],"category_scores_gemma":[0.002240539,0.0004742104,0.001016538,0.002711459,0.0003509289,0.0008506476,0.0008439613,0.000808718,0.0001649278],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008636119,"about_ca_system_score_gemma":0.0007662628,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.02273158,"about_ca_topic_score_gemma":0.02632924,"domain_scores_codex":[0.9988106,0.000254524,0.0002614921,0.0003076371,0.0001938055,0.000171904],"domain_scores_gemma":[0.9971565,0.0003581721,0.001854343,0.0001717573,0.0002174963,0.0002416662],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00006998723,0.00002123892,0.998882,0.00001254859,0.0001357883,0.00003624606,0.00002749564,0.00006549927,0.00005532682,0.00002988093,0.0002276472,0.0004362547],"study_design_scores_gemma":[0.000008385535,0.00003595826,0.9985046,0.00001362064,0.00006324374,0.0002366632,0.0002585765,0.000520014,0.00004944431,0.00003408059,0.0002674586,0.000008053377],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9923205,0.0007881582,0.0001306813,0.0001766854,0.0000111318,0.000009772996,0.006122817,0.000007762601,0.0004325174],"genre_scores_gemma":[0.996639,0.0002835569,0.0000770228,0.00007923567,0.00001246702,0.00000920603,0.002821143,0.000002293779,0.00007602215],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02273158,"threshold_uncertainty_score":0.0451985,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02334276139145518,"score_gpt":0.3478041825949271,"score_spread":0.3244614212034719,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}